Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
Arun K. Ghosh, Margherita Brindisi, Dana Shahabi, et al.
ChemMedChem (2020) Vol. 15, Iss. 11, pp. 907-932
Open Access | Times Cited: 296

Showing 1-25 of 296 citing articles:

PROTAC targeted protein degraders: the past is prologue
Miklós Békés, David R. Langley, Craig M. Crews
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 181-200
Open Access | Times Cited: 1867
COVID-19: Drug Targets and Potential Treatments
Carmen Gil, Tiziana Ginex, Inés Maestro, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12359-12386
Open Access | Times Cited: 439
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
Theresa Klemm, Gregor Ebert, Dale J. Calleja, et al.
The EMBO Journal (2020) Vol. 39, Iss. 18
Open Access | Times Cited: 436
COVID-19: Discovery, diagnostics and drug development
Tarik Asselah, David Durantel, Éric Pasmant, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 168-184
Open Access | Times Cited: 412
Employee engagement practices during COVID‐19 lockdown
Nisha Chanana, Sangeeta
Journal of Public Affairs (2020) Vol. 21, Iss. 4
Open Access | Times Cited: 326
A Global Review on Short Peptides: Frontiers and Perspectives
Vasso Apostolopoulos, Joanna Bojarska, Tsun‐Thai Chai, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 430-430
Open Access | Times Cited: 301
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
Chunhui Zhang, Elizabeth A. Stone, M.G. Deshmukh, et al.
ACS Central Science (2021) Vol. 7, Iss. 3, pp. 467-475
Open Access | Times Cited: 231
Antiviral drug discovery: preparing for the next pandemic
Catherine S. Adamson, Kelly Chibale, Rebecca J. M. Goss, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 6, pp. 3647-3655
Open Access | Times Cited: 201
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
Shalki Choudhary, Kajal Sharma, Om Silakari
Microbial Pathogenesis (2020) Vol. 150, pp. 104673-104673
Open Access | Times Cited: 198
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hironori Hayashi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 180
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
Zhengnan Shen, Kiira Ratia, Laura Cooper, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2940-2955
Open Access | Times Cited: 177
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
Sk. Abdul Amin, Suvankar Banerjee, Kalyan Ghosh, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 29, pp. 115860-115860
Open Access | Times Cited: 175
Antivirals for COVID-19: A critical review
Andri Frediansyah, Ruchi Tiwari, Khan Sharun, et al.
Clinical Epidemiology and Global Health (2020) Vol. 9, pp. 90-98
Open Access | Times Cited: 174
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET
Sunil Thomas
Pathogens and Immunity (2020) Vol. 5, Iss. 1, pp. 342-342
Open Access | Times Cited: 158
Optical Biosensors for Virus Detection: Prospects for SARS‐CoV‐2/COVID‐19
Hemanth Maddali, Catherine E. Miles, Joachim Kohn, et al.
ChemBioChem (2020) Vol. 22, Iss. 7, pp. 1176-1189
Open Access | Times Cited: 151
Autoimmune complications of COVID‐19
Niloufar Yazdanpanah, Nima Rezaei
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 54-62
Open Access | Times Cited: 149
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
Naoya Kitamura, M. Sacco, Chunlong Ma, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2848-2865
Open Access | Times Cited: 135
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity
Chunlong Ma, Zilei Xia, M. Sacco, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 49, pp. 20697-20709
Open Access | Times Cited: 122
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
Haozhou Tan, Yanmei Hu, Prakash D. Jadhav, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7561-7580
Open Access | Times Cited: 118
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)
Sang Hoon Han, Christopher M. Goins, T. Arya, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2880-2904
Open Access | Times Cited: 108
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
Daniel W. Kneller, Hui Li, G.N. Phillips, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 100
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19
Hengrui Liu, Sho Iketani, Arie Zask, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 79
Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
Zongyang Lv, Kristin E. Cano, Lijia Jia, et al.
Frontiers in Chemistry (2022) Vol. 9
Open Access | Times Cited: 77
Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Xin Li, Yongcheng Song
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115772-115772
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top